Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis

Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis

ABSTRACT Multidrug-resistant tuberculosis (MDR-TB) is often associated with poor clinical outcomes. In this study, we evaluated the potential of nosiheptide (NOS) as a new drug candidate for treating Mycobacterium tuberculosis infections, including MDR-TB. The antimicrobial susceptibility testing wa...

Full description

Bibliographic Details
Main Authors: Xia Yu, Rui Zhu, Zhi Geng, Yaoyao Kong, Fen Wang, Lingling Dong, Liping Zhao, Yi Xue, Xiaochi Ma, Hairong Huang
Format: Article
Language:English
Published: American Society for Microbiology 2022-12-01
Series:Microbiology Spectrum
Subjects:
Mycobacterium tuberculosis
nosiheptide
antimicrobial activity
intracellular activity
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01444-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.01444-22

Similar Items